Global Accessibility Focus Co-Diagnostics emphasizes democratizing molecular diagnostics, with a mission to provide affordable high-quality PCR testing particularly in remote and underserved regions. This strategic focus presents opportunities to partner with health organizations and governments seeking cost-effective diagnostic solutions worldwide.

Innovative Platform The company has developed patented Co-Primers technology and is preparing to launch the PCR Pro platform, enabling real-time PCR testing at the point-of-care and at home. This positions Co-Dx as a potential supplier of advanced, user-friendly diagnostic devices suitable for home testing and decentralized healthcare markets.

Market Engagement Active participation in international health conferences and exhibitions such as the Global Health Exhibition and the Union World Conference illustrates Co-Dx's effort to expand its market reach and engage with key stakeholders globally, creating openings for global distribution and collaboration opportunities.

Funding and Growth Recent financing rounds securing new capital, despite current revenue levels below one million dollars, suggest potential for scaling operations and expanding sales channels, especially within government and institutional sectors seeking innovative diagnostic solutions.

Partnership Potential With a focus on infectious disease detection including tuberculosis, Co-Dx’s technology offers significant sales opportunities with public health agencies and laboratories aiming for accessible, rapid, and reliable testing methods, especially in areas with high disease prevalence.